![Daniel Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Clark
Geen lopende functies
Profiel
Daniel Clark worked as a Manager at The Siegfried Group LLP from 2018 to 2020.
He then worked as the Chief Financial Officer at Kiromic Biopharma, Inc. from 2021 to 2022.
Clark holds an MBA from Mays Business School and an undergraduate degree from Robins E.
Claiborne School of Business.
Eerdere bekende functies van Daniel Clark
| Bedrijven | Functie | Einde |
|---|---|---|
| KIROMIC BIOPHARMA, INC. | Financieel Directeur/CFO | 23-12-2022 |
The Siegfried Group LLP
 The Siegfried Group LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01-02-2020 |
Opleiding van Daniel Clark
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The Siegfried Group LLP
The Siegfried Group LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Mays Business School
 Mays Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robins E. Claiborne School of Business
 Robins E. Claiborne School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiromic Biopharma, Inc.
 Kiromic Biopharma, Inc. BiotechnologyHealth Technology Develops cancer engineered immunotherapies | Health Technology |
